Diabetes

The number of individuals living with diabetes worldwide significantly increased between 1980 and 2014.

Patients with T2D who get the flu shot may have a reduced risk for hospitalization related to cardiovascular or respiratory issues.

All evidence points to metformin as the first-line oral diabetes treatment for patients with T2D, but research indicates that clinicians often fail to prescribe it when indicated.

T cell subset may play a crucial role in the development of diabetes.

Insulin therapy must be individualized and balanced with meal planning and exercise.

Insulin therapy must be individualized and balanced with meal planning and exercise.

With a diagnosis of diabetes comes suggested dietary changes and new medications, which, in addition to the array of available diabetes devices, can make patients feel overwhelmed.

Formerly known as juvenile-onset diabetes, type 1 diabetes (T1D) is an endocrine disorder characterized by hyperglycemia due to insulin deficiency.

Practice guidelines include incretin-based therapies as alternative monotherapy agents when metformin is contraindicated or as a component of combination therapy.

Which OTC products should these pharmacists recommend?

Study finds clinicians prescribe metformin less often than they should.

Current guidelines for type 2 diabetes management recommend metformin as the first-line medication.

A new grant will fund a 5-year study on how mobile technology can assist minority patients with diabetes treatment adherence.

Top news of the day from across the health care landscape.

Metformin hydrochloride extended-release tablets are the generic version of Fortamet, which improves glycemic control in type 2 diabetes mellitus.

Mylan has launched metformin hydrochloride extended-release tablets, the generic version of Watson's Fortamet, in 500 mg and 1000 mg doses.

The increasing incidence of diabetes is outpacing the number of health care providers skilled in caring for affected patients.

Approximately 40% of whites and 50% of blacks over 45-years-old developed high blood pressure over 10 years.

Continuous glucose monitoring system provides health care professionals with clear, visual snapshots of glucose levels.

The FDA has approved a new continuous glucose monitoring (CGM) system designed to provide health care professionals with clear, visual snapshots of glucose levels, trends, and patterns in patients with diabetes at a lower cost than other CGM devices on the market.

New study may have found a way to prevent the loss of physical strength in type 1 diabetes patients.

Top news of the day from across the health care landscape.

First automated insulin delivery device approved for patients 14 years and older with type 1 diabetes.

Novo Nordisk has submitted a supplemental application to the FDA to include data from the 2 phase 3b SWITCH trials in the prescribing information for insulin degludec (Tresiba), a once-daily basal insulin that provides a duration of action beyond 42 hours for patients with type 1 and type 2 diabetes.